SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

MaxLinears plans to enter the 1.6T active electrical cable market Credo dominates have raised concerns about future competition and contributed to a sharp selloff. Traders are split between viewing the decline as an overreaction and buying opportunity, given Credos incumbent position and AI data-center demand, and worrying about market-share losses and further downside.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Traders are focused on CRISPR Therapeutics CTX310 Phase 1b data presentation at the AHA conference, with speculation that results could validate its in vivo gene-editing approach for cardiovascular disease. Some are positioning ahead of the readout, while others doubt the stock will break out of its long-running range even if the data are encouraging.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys earnings beat and raised outlook, driven by strong QNX performance, are drawing attention alongside Alloy Kores first major design win and a newly disclosed Uber selection of QNX for next-generation vehicles. Many traders see these developments and expanding QNX opportunities in automotive and physical AI as bullish, while others question why the share price has not sustained a stronger reaction and point to market pressure.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas strong run to new highs is drawing attention as investors rotate toward defensive consumer-staples stocks amid weakness in tech. Traders are split between backing the momentum and warning that the rally has stretched the valuation; some also point to KFCs planned switch to Coke beverages as a positive business development.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is caught in a choppy debate over small caps amid elevated oil prices and U.S.-Iran tensions, which traders fear could stoke inflation and complicate the Feds rate decision. Some see the pressure as bearish for small caps, while others point to their relative resilience and potential rotation into the group as yields ease.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs reported push into wirelessincluding plans for broad cell-site accesshas weighed on AT&T amid fears of a new competitor. Traders debate whether the threat is being overestimated given the years and investment needed to build a network, while dip buyers point to AT&Ts strong results and dividend.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Encouraging preliminary Phase 1 azer-cel results in progressive MSshowing stable or improved disability scores for most evaluable patients and no severe treatment-related toxicitiesare driving attention. Traders see the findings as promising pipeline upside, but some argue the small, early-stage study has had limited stock impact and are focused on upcoming BRIUMVI data and earnings.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows rebound into its quarterly earnings is drawing attention, with analyst upgrades and optimism about enterprise AI adoption and AI-agent governance cited as support. Bulls view the strength as part of a recovery in software and a rotation away from chip stocks, while skeptics point to valuation, sharp reversals, and the risk of a post-earnings pullback.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys strong run toward its highs is drawing attention as traders position around its scheduled Q3 earnings report, with analyst upgrades, merchant growth, and AI-powered commerce cited as bullish supports. Others see the rally as extended and expect volatility or a pullback into the report.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa has put FDA acceptance and the review timeline at the center of discussion. Traders are divided over the drugs approval prospects and commercial potential, with optimism about its clinical data countered by concerns about regulatory risk, managements plan to commercialize independently, and possible future dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
